Catheter ablation of drug induced atrial flutter in patients with recurrent atrial fibrillation;Katheterablation von antiarrhythmika-induziertem vorhofflattern bei patienten mit rekurrierendem vorhofflimmern

Herzschrittmachertherapie und Elektrophysiologie

Volumn 14, Issue 1, 2003, Pages 8-14

  Bielik, H ^b   Yang, A ^b   Schwab, J O ^b   Schrickel, J ^b   Bitzen, A ^b   Balta, O ^b   Held, S ^b   Luderitz B ^b   Lewalter, Thorsten ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b NONE

Author keywords

Atrial fibrillation; Atrial flutter; Catheter Ablation; Hybrid therapy

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE; PROPAFENONE; QUINIDINE;

ABLATIVE HYBRID THERAPY; ARTICLE; CATHETER ABLATION; DISEASE SEVERITY; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART ELECTROPHYSIOLOGY; HEART RHYTHM; HUMAN; QUALITY OF LIFE; RECURRENT DISEASE; SINUS RHYTHM; TREATMENT OUTCOME;

EID: 0344238738     PISSN: 09387412     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00399-003-0370-0     Document Type: Article

References (16)

1. Bielik H, Schrickel J, Shlevkov N, Yang A, Schwab J, Burkhardt D, Schimpf R, Yeong K, Herwig S, Lüderitz B, Lewalter T (2002) Catheter ablation of drug induced atrial flutter: impact on atrial fibrillation recurrences and quality of life. Eur Heart J 4:658 (abstract)
2. Cosio FG, Lopez M, Gociolea A, Arribas F, Barroso JL (1993) Radiofrequency ablation of the inferior vena cava-tricuspid valve isthmus in common atrial flutter. Am J Cardiol 71:705-709
3. Dorian P, Jung W, Newman M, Wood K, Ayers GM, Camm J, Akhtar M, Lüderitz B (2000) The impairment of health-related quality of life in patient with intermittent atrial fibrillation. Implications for the assessment of investigational therapy. J Am Coll Cardiol 36:1303-1309
4. Feld GK, Fleck RP, Chen PS, Boyce K, Bahnson TD, Stein JB, Calisi CM, Ibarra M (1992) Radiofrequency catheter ablation for the treatment of human type I atrial flutter. Identification of a critical zone in the reentrant circuit by endocardial mapping techniques. Circulation 86:1233-1240
5. Garrey WE (1924) Auricular fibrillation. Physiol Rev 4:215-250
6. Huang DT, Monahan KM, Zimetbaum P, Papageorgion P, Epstein LM, Josephson ME (1998) Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 9:462-469
7. Lewalter T, Yang A, Schrickel J, Schimpf R, Bielik H, Herwig S, Esmailzadech B, Welz A, Lüderitz B (2001) Novel Pacing Algorithms Applied in Hybrid Therapies of Atrial Fibrillation: the Ultimate Solution? In: Raviele A (Hrsg) Cardiac Arrhythmias. Springer, Italia, Milan, S 542-546
8. Nabar A, Rodriguez LM, Timmermans C, Smeets JL, Wellens HJ (1999) Radiofrequency ablation of "class IC atrial flutter" in patients with resistant atrial fibrillation. Am J Cardiol 83:785-787
9. Nabar A, Rodriguez LM, Timmermans C, Mechelen R, Wellens HJJ (2001) Class IC antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long-term outcome after right atrial isthmus ablation. Heart 85:424-429
10. Reithmann C, Hoffmann E, Spitzberger G, Dorwarth U, Gerth A, Remp T, Steinbeck G (2000) Catheter ablation of atrial flutter due to amiodarone therapy for paroxysmal atrial fibrillation. Eur Heart J 21:565-572
11. Riva S, Tondo C, Carbucicchio C, Galimberti P, Fassini G, Della Bella P (1999) Incidence and clinical significance of transformation of atrial fibrillation to atrial flutter in patients undergoing long-term antiarrhythmic drug treatment. Europace 1:242-247
12. Schumacher B, Jung W, Lewalter T, Vahlhaus C, Wolpert C, Lüderitz B (1999) Radiofrequency ablation of atrial flutter due to administration of class IC antiarrythmic drugs for atrial fibrillation. Am J Cardiol 83:710-713
13. Schumacher B, Lewalter T, Wolpert C, Jung W, Lüderitz B (1998) Radiofrequency catheter ablation of atrial flutter. J Cardiovasc Electrophysiol 9:139-146
14. Stabile G, Simone A, Turco P, Turco P, La Rocca V, Nocerino P, Astarita C, Maresca F, De Matteis C, Di Napoli T, Stabile E, Vitale DF (2001) Response to flecainide infusion predictors long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation. J Am Coll Cardiol 37:1639-1644
15. Tai CT, Ching CE, Lee SH, Chen YJ, Yu WC, Feng AN, Ding YA, Chang MS, Chen SA (1999) Persistent atrial flutter in patients treated for atrial fibrillation with amiodarone and propafenone: Electrophysiologic characteristics, radiofrequency catheter ablation, and risk prediction. J Cardiovasc Electrophysiol 10:1180-1187
16. Van der Berg MP, Hassink RJ, Tuinenburg AE, van Sonderen EFLP, Lefrandt JD, Kam PJ, Gelder JC, Smit AJ, Sanderman R, Crijns HJGM (2001) Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system. Eur Heart J 22:247-253